The Cancer Immunoprevention Network (CIP-Net), established by the National Cancer Institute (NCI), advances the understanding of fundamental immunoprevention mechanisms, drives the discovery of novel strategies, and supports the preclinical development and testing of new interventions. More info: nci-cipnet.org

What if bacteria could be programmed to find tumors and deliver cancer therapies directly where they're needed? A new @NatureCancer Perspective by Noah Chen, Zaofeng Yang, and Nicholas Arpaia @arpaialab explores the promise of engineered bacteria as living therapeutics, discussing tumor colonization, antitumor mechanisms, and strategies to improve therapeutic delivery. Read the article: rdcu.be/fmtyo #CancerResearch #Immunotherapy #SyntheticBiology #Microbiome #NatureCancer

🚨 BREAKING: A "holy grail" moment for lung cancer prevention. Funded in part by a @TheMarkFdn ASPIRE Award & published in @CellCellPress, @CharlesSwanton & team have discovered a 14-protein blood signature that can predict lung cancer risk over 5 years before a diagnosis. 🧵👇 themarkfoundation.org/portfo…

Join the @theNCI Division of Cancer Prevention Immunology Interest Group for a special seminar presentation on Wednesday June 10 at 1pm ET. We will hear from Dr. Nicholas Arpaia @arpaialab, Associate Professor of Microbiology & Immunology at the @Columbia Herbert Irving Comprehensive Cancer Center discussing his research in: "Programmable Probiotics for Personalized Cancer Immunoprevention and Immunotherapy." Register today: go.nih.gov/QysclHR #CancerResearch #CancerPrevention

⏲️Faster clinical trial activation means faster access to innovation. During today’s #ASCO26 panel, @NCIDirector discussed the importance of aligning stakeholders, supporting cancer centers with guidance and incentives, sharing best practices, and partnering across @HHSGov.

Cancer Immunotherapy Month kicks off June 1! Join CRI for a monthlong celebration of the scientific breakthroughs, translational advances, and pioneering research continuing to push the immunotherapy field forward. #CancerResearch #Immunotherapy

Register now for the @theNCI Division of Cancer Prevention Early Career Scientist Spotlight Research Seminar Series. events.cancer.gov/dcp/early-…

NEW content online! Regulation of immune checkpoint molecules in cancer immune evasion and therapy dlvr.it/TSbsh5

Cancer type-specific variation in patterns of driver alterations across 50,000 tumors dlvr.it/TSWtCg

⭐Out today! Read the phase I clinical trial on neoantigen DNA vaccine for patients with glioblastoma nature.com/articles/s43018-0…

New #JITC article: "CAR-engineering of innate and innate-like immune cells: a new horizon in adoptive cell therapy for solid tumors" jitc.bmj.com/content/14/5/e0… @AliceIndini

Join the conversation shaping the future of cancer care at the NCI workshop “Precision in Practice: A Functional Medicine Workshop” on July 1-2, 2026 at @theNCI Shady Grove Campus and online. Day 1 will highlight the current state-of-the-art in functional precision medicine, featuring a keynote presentation by Dr. Anthony Letai @NCIDirector. Day 2 will focus on defining the key scientific questions that will shape the next decade of cancer care. The workshop will bring together leaders from academia, industry, government, and patient advocacy to accelerate the translation of functional precision oncology into clinical practice. Explore the draft agenda and register today: events.cancer.gov/OD/functio… #CancerResearch #PrecisionMedicine #FunctionalPrecisionMedicine #Oncology #CancerCare

A curated list of NIH/NCI shared resources is now available on our web portal. Check it out: nci-cipnet.org/en/resources/…

Great kickoff for the CIP-Net Resource Sharing WG today! 🚀 Many thanks to WG Chairs Dr. Anjana Bhardwaj of @UTMDAnderson and Dr. Henry Withers of @RoswellPark for leading a thoughtful discussion on building a collaborative framework for resource sharing across the network. And thank you to all members for the active participation and valuable input. Looking forward to what we build together! #CIPNet #CancerImmunoprevention #TeamScience

Community input needed!

Online Now: T cell extracellular vesicles go nuclear to turn cold tumors hot dlvr.it/TSJd1y

New review just out in Nature Reviews Drug Discovery: Drs. Erik S. Knudsen, Agnieszka K. Witkiewicz, and Sheheryar Kabraji of @RoswellPark outline the evolving landscape of CDK inhibition: from the success of CDK4/6 inhibitors in breast cancer to next-gen strategies expanding into other tumor types. From combination therapies (HER2, PI3K) to CDK2 targeting and biomarker-guided patient selection, this piece captures where the field is heading a decade after first FDA approvals. #CancerResearch #CDK #BreastCancer #TargetedTherapy

In a new #ScienceReview, researchers discuss a variety of methods to reimagine human-centric drug development. Learn more: scim.ag/41SHtuZ

mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expression go.nature.com/4eSjV0N

📢Today we launch our Series on Tumor Heterogeneity and Plasticity featuring commissioned Reviews and a selection of articles published in Nature Cancer! Read about EMT, CAF plasticity, immune cell plasticity, cellular neighborhoods and more here: 🔗nature.com/collections/gfbbj…